Analgesic effect of TAK-242 on neuropathic pain in rats

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 7, 2015, Pages 11202-11207

  Zhao, Yang ^a   Xin, Yan ^b   Gao, Jie ^a   Teng, Ru Yang ^a   Chu, Hai Chen ^a  

^a QINGDAO UNIVERSITY   (China)

^b QINGDAO MUNICIPAL HOSPITAL   (China)

Author keywords

Neuropathic pain; TAK 242

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELL INHIBITOR ALPHA; NUCLEAR FACTOR; RESATORVID; SYNAPTOTAGMIN I; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR ASSESSMENT; CONTROLLED STUDY; DOWN REGULATION; DRUG MEGADOSE; ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEAT PAIN; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; MALE; MECHANICAL PAIN; NERVE COMPRESSION; NEUROPATHIC PAIN; NONHUMAN; PAIN THRESHOLD; POSTOPERATIVE PERIOD; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

EID: 84940655356     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Wang JW, Zhao HR. Advances in the treatment of neuropathic pain. Chinese J of Pain Med 2013; 19: 366-369.
2. Wu FX, Bian JJ, Miao XR, Huang SD, Xu XW, Gong DJ, Sun YM, Lu ZJ, Yu WF. Intrathecal siRNA against Toll-like receptor 4 reduces nociception in a rat model of neuropathic pain. Int J Med Sci 2010; 7: 251-259.
3. Kuang X, Huang Y, Gu HF, Zu XY, Zou WY, Song ZB, Guo QL. Effects of intrathecal epigallocatechin gallate, an inhibitor of Toll-like receptor 4, on chronic neuropathic pain in rats. Eur J Pharmacol 2012; 676: 51-56.
4. Wang X, Grace PM, Pham MN, Cheng K, Strand KA, Smith C, Li J, Watkins LR, Yin H. Rifampin inhibits Toll-like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain. FASEB J 2013; 27: 2713-2722.
5. Paterniti I, Esposito E, Mazzon E, Bramanti P, Cuzzocrea S. Evidence for the role of PI(3)-kinase-AKT-eNOS signalling pathway in secondary inflammatory process after spinal cord compression injury in mice. Eur J Neurosci 2011; 33: 1411-1420.
6. Wang YC, Wang PF, Fang H, Chen J, Xiong XY, Yang QW. Toll-like receptor 4 antagonist attenuates intracerebral hemorrhage-induced brain injury. Stroke 2013; 44: 2545-2552.
7. Garate I, Garcia-Bueno B, Madrigal JL, Caso JR, Alou L, Gomez-Lus ML, Leza JC. Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress. J Neuroinflammation 2014; 11: 8.
8. Gomez R, Villalvilla A, Largo R, Gualillo O, Herrero-Beaumont G. TLR4 signalling in osteoarthritis--finding targets for candidate DMOADs. Nat Rev Rheumatol 2015; 11: 159-170.
9. Martucci C, Trovato AE, Costa B, Borsani E, Franchi S, Magnaghi V, Panerai AE, Rodella LF, Valsecchi AE, Sacerdote P, Colleoni M. The purinergic antagonist PPADS reduces pain related behaviours and interleukin-1 beta, interleukin-6, iNOS and nNOS overproduction in cen-tral and peripheral nervous system after pe ripheral neuropathy in mice. Pain 2008; 137: 81-95.
10. Liu T, Gao YJ, Ji RR. Emerging role of Toll-like receptors in the control of pain and itch. Neurosci Bull 2012; 28: 131-144.
11. Sun T, Luo J, Jia M, Li H, Li K, Fu Z. Small interfering RNA-mediated knockdown of NF-kappaBp65 attenuates neuropathic pain following peripheral nerve injury in rats. Eur J Pharmacol 2012; 682: 79-85.
12. Bettoni I, Comelli F, Rossini C, Granucci F, Giagnoni G, Peri F, Costa B. Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice. Glia 2008; 56: 1312-1319.
13. Rice TW, Wheeler AP, Bernard GR, Vincent JL, Angus DC, Aikawa N, Demeyer I, Sainati S, Amlot N, Cao C, Ii M, Matsuda H, Mouri K, Cohen J. A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit Care Med 2010; 38: 1685-1694.